PRESS RELEASE

<< Back

Lexington Pharmaceuticals changes name to TRACON Pharmaceuticals, Inc. Lexington Pharmaceuticals announced that it has changed its name to TRACON Pharmaceuticals, Inc., and has moved the company from New York, New York to San Diego, California.

April 16, 2005

Lexington Pharmaceuticals changes name to TRACON Pharmaceuticals, Inc. Lexington Pharmaceuticals announced that it has changed its name to TRACON Pharmaceuticals, Inc., and has moved the company from New York, New York to San Diego, California. Bert Liang, President and CEO, noted, “The name TRACON – an acronym for TaRgeted Approach and Control in ONcology – is where we derive our mission and objectives. The development of targeted novel and efficacious therapies is the cornerstone of the goals and objectives of our firm.” Moreover, he added, “Our rationale for the move to San Diego revolved around the biotechnology environment and talent in Southern California. There are over 300 biopharma companies here, which provides an excellent milieu for development stage companies, such as TRACON.”

ABOUT TRACON Pharmaceuticals:
TRACON Pharmaceuticals is a private development stage biopharmaceutical firm formed in January 2005, located in San Diego, CA. TRACON is focused on developing and commercializing effective, novel, targeted therapies for patients with cancer.